Share
Intrathecal Infusion for Targeted Drug Delivery
Dr. David Schultz presents an interesting overview of targeted drug delivery (TDD) through intrathecal infusion. He discusses the history of neural stimulation, the introduction of spinal opioids, and medication delivery to the spine. Dr. Schultz highlights proper patient selection for TDD, compares TDD to neurostimulation, and discusses its pros and cons. He describes available TDD systems from Medtronic and Flownix, trialing, and surgical implant complications.
This experience is powered by CMEfy – an AI-powered platform that directs learners along a pathway to capture reflections at point of inspiration, point of care. Clinicians may earn CME/CE credit via ReflectCE, the accredited activity portal. Learn more at about.cmefy.com/cme-info
Comment
expand_more
expand_less